Join Nostr
2025-12-04 17:01:24 UTC

Ada Palmer on Nostr: Powerful new malaria drug offers first serious alternative to artemisinin in decades. ...

Powerful new malaria drug offers first serious alternative to artemisinin in decades. Novartis’ new drug cured more than 97% of malaria cases in a Phase 3 trial of 1,688 adults and children across 12 African countries, matching or beating current artemisinin-based therapies while killing drug-resistant strains and blocking transmission stages. If regulators approve, it will be the first frontline malaria drug of its kind in over 25 years. Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/new-effective-anti-malaria-drug-could-help-fight-rising-resistance-says-novartis-2025-11-12/
#ShareGoodNewsToo